CALIDI BIOTHERAPEUTICS INC (CLDI)

US3207031010 - Common Stock

0.2275  -0.01 (-5.99%)

After market: 0.235 +0.01 (+3.3%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.0045.00K449.00K0.00
Cost Of Goods
N/A14.00K94.00K0.00
Gross Profit
N/A31.00K355.00K0.00
Operating Expenses
21.89M23.16M10.84M6.77M
Research and Development
N/A7.26M4.67M3.18M
Selling, General, and Administrative Expenses
12.84M15.90M6.16M3.59M
Operating Income
-21.89M-23.13M-10.48M-6.77M
Interest Income/Expense
-715.72K-158.00K-614.00K-163.00K
Other Income/Expense
-338.00K-2.13M237.00K-1.05M
Non Recurring Items
N/A0.00-63.00K57.00K
Income Before Taxes
-23.41M-25.42M-10.92M-7.93M
Income Tax
162.30K11.00K11.00K4.00K
Net Income
-23.57M-25.43M-10.93M-7.94M
EBITDA
N/A-22.87M-10.33M-6.67M
 
Per Share Data
EPS Diluted Total Ops
-0.72-0.56-0.24-0.17
 
Statistics
Gross Profit Margin
N/A68.89%79.06%N/A
Profit Margin
N/A-56504.44%-2434.97%N/A
Operating Profit Margin
N/A-51395.56%-2334.52%N/A

All data in USD

Charts